BIOMAT Database Logo BIOMAT Database Logo

Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferons. 1985

J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.
September 1984, Journal of immunology (Baltimore, Md. : 1950),
J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Augmented tumor-associated antigen expression by interferons.
April 1988, Journal of the National Cancer Institute,
J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Modulation of tumor-associated antigen expression on human pancreatic and prostate carcinoma cells in vitro by alpha- and gamma-interferons.
October 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy,
J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Enzymatic modifications of human fibroblast and leukocyte interferons.
August 1980, Journal of virology,
J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Human leukocyte and fibroblast interferons are structurally related.
June 1980, Nature,
J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Pharmacology of interferons I. Pharmacologic distinctions between human leukocyte and fibroblast interferons.
January 1979, International journal of immunopharmacology,
J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin.
February 1988, The Journal of clinical investigation,
J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Sensitivity of rhinoviruses to human leukocyte and fibroblast interferons.
June 1976, The Journal of infectious diseases,
J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Differences between human alpha (leukocyte) and beta (fibroblast) interferons.
January 1981, Archives of virology,
J W Greiner, and J Schlom, and S Pestka, and J A Langer, and P Giacomini, and M Kusama, and S Ferrone, and P B Fisher
Neutralizing antibodies against human leukocyte, lymphoblastoid and fibroblast interferons elicited by immunization with human leukocyte interferon.
December 1978, Acta pathologica et microbiologica Scandinavica. Section C, Immunology,
Copied contents to your clipboard!